Therapeutic Innovation & Regulatory Science

Search all Therapeutic Innovation & Regulatory Science articles

Volume 46, Issue 2

March 2012

15 articles in this issue

Editor’s Commentary: Ethics in Clinical Research
J. Rick Turner
Commentary 30 December 2012 Pages: 155 - 157
Associate Editor’s Commentary: PEEKABOO—ETASU!
Peter J. Pitts
Commentary 30 December 2012 Pages: 158 - 159
Practical Considerations and Strategies for Executing Adaptive Clinical Trials
Weili He
Olga M. Kuznetsova
Jerald Schindler
Clinical Trials 30 December 2012 Pages: 160 - 174
Testing in a Prespecified Subgroup and the Intent-to-Treat Population
Mark D. Rothmann
Jenny J. Zhang
Thomas R. Fleming
Clinical Trials 30 December 2012 Pages: 175 - 179
Industry Support of Key Opinion Leaders
Elizabeth Neglia
Nina Singh-Radcliff
W. Andrew Kofke
Drug Information 30 December 2012 Pages: 180 - 184
Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force
Richard Gliklich
Judith Glennie
Nancy A. Dreyer
Drug Information 30 December 2012 Pages: 185 - 191
An Exploratory Analysis of Pharmaceutical Drugs as Basic Research Tools
John E. Calfee
Elizabeth DuPré
Drug Information 30 December 2012 Pages: 192 - 196
Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products
J. Michael Nicholas
Drug Information 30 December 2012 Pages: 197 - 206
Consumer Dynamics in a Nonmature Generic Drugs Market: A Causal Model Explaining Intention to Purchase in Spain
Mónica Gómez
Mercedes Rozano
Drug Information 30 December 2012 Pages: 207 - 215
Transparency in Drug Submission Processes of 3 Asian Countries: A Survey of Industry Views
Martin Solberg
Frances J. R. Richmond
Drug Information 30 December 2012 Pages: 216 - 225
Content Analysis of Television Advertising for Drugs That Switch From Prescription to Over-the-Counter: Balancing Information and Appeals
Adrienne E. Faerber
David H. Kreling
Drug Information 30 December 2012 Pages: 226 - 234
Review of Genotoxic Impurities: Strategies for Identification and Control
Theresa Allio
Book Reviews 30 December 2012 Pages: 235 - 236
Review of Translational Medicine and Drug Discovery
Edward Tabor
Book Reviews 30 December 2012 Pages: 237 - 237
Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs
Frank J. Sasinowski
Special Section 30 December 2012 Pages: 238 - 263
2012 EuroMeeting Student Poster Abstracts

Abstracts 30 December 2012 Pages: 264 - 271

Volume 46, Issue 2

Editor’s Commentary: Ethics in Clinical Research

Associate Editor’s Commentary: PEEKABOO—ETASU!

Practical Considerations and Strategies for Executing Adaptive Clinical Trials

Testing in a Prespecified Subgroup and the Intent-to-Treat Population

Industry Support of Key Opinion Leaders

Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force

An Exploratory Analysis of Pharmaceutical Drugs as Basic Research Tools

Complex Drugs and Biologics: Scientific and Regulatory Challenges for Follow-on Products

Consumer Dynamics in a Nonmature Generic Drugs Market: A Causal Model Explaining Intention to Purchase in Spain

Transparency in Drug Submission Processes of 3 Asian Countries: A Survey of Industry Views

Content Analysis of Television Advertising for Drugs That Switch From Prescription to Over-the-Counter: Balancing Information and Appeals

Review of Genotoxic Impurities: Strategies for Identification and Control

Review of Translational Medicine and Drug Discovery

Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs

2012 EuroMeeting Student Poster Abstracts

Journal navigation